Literature DB >> 16777994

Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2.

Alpna Tyagi1, Rana P Singh, Chapla Agarwal, Rajesh Agarwal.   

Abstract

Silibinin, a natural flavonolignan, induces apoptosis in human bladder transitional-cell papilloma RT4 cells both in vitro and in vivo; however, mechanisms of such efficacy are not completely identified. Here, we studied the mechanisms involved in silibinin-induced apoptosis of RT4 cells having intact p53. Silibinin increased p53 protein level together with its increased phosphorylation at serine 15, activated caspase cascade and caused Bid cleavage for apoptosis. Silibinin-caused p53 activation was mediated via ATM-Chk2 pathway, which in turn induced caspase 2-mediated apoptosis. Pifithrin-alpha, a p53 inhibitor, reversed silibinin-induced caspase activation including caspase 2; however, caspase 2 inhibitor also reversed p53 phosphorylation suggesting a bidirectional regulation between them. Further, silibinin caused a rapid translocation of p53 and Bid into mitochondria leading to increased permeabilization of mitochondrial membrane and cytochrome c release into the cytosol. JNK1/2 activation was observed as a connecting link for p53-mediated caspase 2 activation. Interestingly, silibinin-induced apoptosis was mediated, in part, via Cip1/p21 cleavage by caspase, which was reversed by Cip1/p21 siRNA. Together, these results suggested the novel mechanisms for apoptosis induction by silibinin involving p53-caspase 2 activation and caspase-mediated cleavage of Cip1/p21.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16777994     DOI: 10.1093/carcin/bgl098

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

1.  Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.

Authors:  Eun-Sun Choi; Sejun Oh; Boonsil Jang; Hyun-Ju Yu; Ji-Ae Shin; Nam-Pyo Cho; In-Hyoung Yang; Dong-Hoon Won; Hye-Jeong Kwon; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Oncol (Dordr)       Date:  2017-04-11       Impact factor: 6.730

2.  A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.

Authors:  Nicole Baptiste-Okoh; Anthony M Barsotti; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

3.  Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.

Authors:  Keqin Ren; Jing Lu; Aleksey Porollo; Chunying Du
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

Review 4.  Caspases and cancer.

Authors:  M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2011-04-01       Impact factor: 15.828

Review 5.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 6.  Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer.

Authors:  Harold Ting; Gagan Deep; Rajesh Agarwal
Journal:  AAPS J       Date:  2013-04-16       Impact factor: 4.009

7.  Silibinin induced the apoptosis of Hep-2 cells via oxidative stress and down-regulating survivin expression.

Authors:  Xinxin Yang; Xiaoyu Li; Liangxiang An; Bo Bai; Jing Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-12       Impact factor: 2.503

Review 8.  Multitargeted therapy of cancer by silymarin.

Authors:  Kumaraguruparan Ramasamy; Rajesh Agarwal
Journal:  Cancer Lett       Date:  2008-05-09       Impact factor: 8.679

Review 9.  Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?

Authors:  Sharad Kumar
Journal:  Nat Rev Cancer       Date:  2009-11-05       Impact factor: 60.716

10.  Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells.

Authors:  G Ramakrishnan; L Lo Muzio; C M Elinos-Báez; S Jagan; T A Augustine; S Kamaraj; P Anandakumar; T Devaki
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.